Literature DB >> 35128632

Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib.

Amy Zhou1, Tim Kong1, Jared S Fowles1, Chun-Ling Jung2, Maggie J Allen1, Daniel A C Fisher1, Mary Fulbright1, Elizabeta Nemeth2, Tomas Ganz2, Stephen T Oh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35128632     DOI： 10.1111/bjh.18044

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Transfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis.

Authors:  Nicole K Yun; Taha Alrifai; Ira J Miller; Jamile M Shammo
Journal:  Case Rep Oncol       Date:  2022-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.